Photocross-linking of nascent chains to the STT3 subunit of the oligosaccharyltransferase complex.

J Cell Biol

Department of Medical Biochemistry and Genetics, Texas A&M University System Health Science Center, College Station, TX 77843, USA.

Published: May 2003

AI Article Synopsis

  • Eukaryotic cells modify polypeptides by N glycosylation during their translocation into the ER lumen, mediated by the oligosaccharyltransferase (OST) enzyme.
  • Researchers successfully cross-linked an OST subunit to a nascent polypeptide chain while it was being integrated into the ER membrane using a photoreactive probe.
  • The findings suggest that the STT3 subunit of OST is crucial for the glycosylation process, as no other OST subunits were cross-linked in this context.

Article Abstract

In eukaryotic cells, polypeptides are N glycosylated after passing through the membrane of the ER into the ER lumen. This modification is effected cotranslationally by the multimeric oligosaccharyltransferase (OST) enzyme. Here, we report the first cross-linking of an OST subunit to a nascent chain that is undergoing translocation through, or integration into, the ER membrane. A photoreactive probe was incorporated into a nascent chain using a modified Lys-tRNA and was positioned in a cryptic glycosylation site (-Q-K-T- instead of -N-K-T-) in the nascent chain. When translocation intermediates with nascent chains of increasing length were irradiated, nascent chain photocross-linking to translocon components, Sec61alpha and TRAM, was replaced by efficient photocross-linking solely to a protein identified by immunoprecipitation as the STT3 subunit of the OST. No cross-linking was observed in the absence of a cryptic sequence or in the presence of a competitive peptide substrate of the OST. As no significant nascent chain photocross-linking to other OST subunits was detected in these fully assembled translocation and integration intermediates, our results strongly indicate that the nascent chain portion of the OST active site is located in STT3.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199356PMC
http://dx.doi.org/10.1083/jcb.200301043DOI Listing

Publication Analysis

Top Keywords

nascent chain
24
nascent chains
8
stt3 subunit
8
translocation integration
8
chain photocross-linking
8
nascent
7
ost
6
chain
6
photocross-linking
4
photocross-linking nascent
4

Similar Publications

Single-Site Catalyst for the Synthesis of Disentangled Ultra-High-Molecular-Weight Polyethylene.

Polymers (Basel)

January 2025

Sinopec Key Laboratory of Research and Application of Medical and Hygienic Materials, SINOPEC (Beijing) Research Institute of Chemical Industry Co., Ltd., No. 14 Beisanhuan Donglu, Chao Yang District, Beijing 100013, China.

Disentangled ultra-high-molecular-weight polyethylene (-UHMWPE) solves the problem of the difficult processing of traditional UHMWPE caused by entanglements between molecular chains. In this review, we look into the innovative realm of nascent disentangled UHMWPE, concentrating on the recent advances achieved through the in situ polymerization of ethylene by single-site catalysts. The effect of single-site catalysts and polymerization conditions on the molecular characteristics is discussed in detail from the perspective of mechanism and DFT calculations.

View Article and Find Full Text PDF

The bacterial chaperone Trigger factor (TF) binds to ribosome-nascent chain complexes (RNCs) and cotranslationally aids the folding of proteins in bacteria. Decades of studies have given a broad, but often conflicting, description of the substrate specificity of TF, its RNC-binding dynamics, and competition with other RNC-binding factors, such as the Signal Recognition Particle (SRP). Previous RNC-binding kinetics experiments were commonly conducted on stalled RNCs in reconstituted systems, and consequently, may not be representative of the interaction of TF with ribosomes translating mRNA in the cytoplasm of the cell.

View Article and Find Full Text PDF

Background: Increased ribosome biogenesis is required for tumor growth. In this study, we investigated the function and underlying molecular mechanism of ribosome biogenesis factor (RBIS) in the progression of non-small cell lung cancer (NSCLC).

Methods: In our study, we conducted a comprehensive analysis to identify key genes implicated in ribosome biogenesis by leveraging a Gene Set Enrichment Analysis (GSEA) dataset.

View Article and Find Full Text PDF

Health System Purchasing Professionals' Approaches to Considering Equity in Procurement.

Chest

December 2024

School of Medicine, Johns Hopkins University, Baltimore, MD, USA; School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Center for Health Equity, Johns Hopkins University, Baltimore, MD, USA.

Background: Continuing data on racial bias in pulse oximeters and artificial intelligence has sparked calls for health systems to drive innovation against racial bias in healthcare device and artificial intelligence markets by incorporating equity concerns explicitly into purchasing decisions.

Research Question: How do healthcare purchasing professionals integrate equity concerns into purchasing decision-making?

Study Design And Methods: Between 8/2023-3/2024, we conducted semi-structured interviews via videoconferencing with healthcare purchasing professionals about purchasing processes for pulse oximeters and other devices-and whether and where equity concerns arise in decision-making. An abductive approach was used to analyze perspectives on how equity and disparity concerns are currently integrated into healthcare purchasing decision-making.

View Article and Find Full Text PDF

CD7-targeting pro-apoptotic extracellular vesicles: A novel approach for T-cell haematological malignancy therapy.

J Extracell Vesicles

December 2024

Department of Orthopaedics of the Second Affiliated Hospital and Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

T-cell haematological malignancies progress rapidly and have a high mortality rate and effective treatments are still lacking. Here, we developed a drug delivery system utilizing 293T cell-derived extracellular vesicles (EVs) modified with an anti-CD7 single-chain variable fragment (αCD7/EVs). Given the challenges of chemotherapy resistance in patients with T-cell malignancy, we selected cytochrome C (CytC) and Bcl2 siRNA (siBcl2) as therapeutic agents and loaded them into αCD7/EVs (αCD7/EVs/CytC/siBcl2).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!